Celltrion's Ramsima Products Garner 74% Market Share in EU5
Celltrion's Ramsima (infliximab) family of products continues to demonstrate market impact with prescription expansion in five major European countries (UK, Germany, France, Spain, and Italy, EU5). According to the pharmaceutical market research firm …